Bone Sarcoma Survival in the US Military Health System: Comparison With the SEER Program

CONCLUSIONS: MHS beneficiaries with bone sarcoma may have longer survival than SEER patients. Our findings support the role of universal access to high-quality care in improving bone sarcoma outcomes.PMID:38684126 | DOI:10.5435/JAAOS-D-23-00897

Source: The Journal of the American Academy of Orthopaedic Surgeons - April 29, 2024 Category: Orthopaedics Authors: Ashley B Anderson Eungjae Kim Amie B Park Kangmin Zhu Jie Lin Craig D Shriver Benjamin K Potter Source Type: research